HistoRx said this week that Heiner Dreismann has joined the company's board of directors.
Dreismann is former president and CEO of Roche Molecular Systems. He was employed by Hoffmann la Roche for 20 years, serving in several roles, including head of global business development for Roche Diagnostics; and head of the PCR business unit for Europe. Dreismann also was a member of Roche Diagnostics' global executive committee.
Thermo Fisher Scientific said this week that it has formed a scientific advisory board "to formalize the two-way exchange of technological information" between the company and academic and research institutions.
The SAB includes: Marc Casper, president and CEO of Thermo Fisher; Tyler Jacks, professor of biology at the Massachusetts Institute of Technology, director of the David H. Koch Institute for Integrative Cancer Research, and a Thermo Fisher board member; Ronald Davis, professor of biochemistry and genetics at Stanford University; Steven Gygi, associate professor of cell biology at Harvard Medical School; William Hahn, associate professor of medicine in the department of medical oncology at Dana-Farber Cancer Institute; and David Hillyard, professor of pathology at the University of Utah.
Sage Science this week announced the appointment of Paul Ventura as director of sales. Paul most recently served as director of North American sales for Covaris.
Sage Science manufactures the Pippin Prep system, which automates DNA size selection for next-gen sequencing and other applications.